Primer, probe and method for detecting respiratory infectious disease pathogen by using liquid chip
A liquid-phase chip detection and respiratory technology, applied in the field of medical monitoring, can solve the problems of many materials required for detection, unfavorable diagnosis of virus infection, and long detection cycle
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
example 1
[0085] It is known that sample 1 contains human respiratory syncytial virus type A (HRSV-A), and it is detected according to the method of the present invention, and the specific steps are as follows:
[0086] a. Extract the total RNA in the sample.
[0087] b. Using the sample total RNA extracted in step a as a template, carry out PCR with primer F and primer R of each virus respectively, and each primer sequence is as follows:
[0088] HRSV A-F: CTGGTCCGTACTTCCGAGCGCAGCTTATCAAATGGAGTTAGTG
[0089] HRSV A-R: TACAGTCGGTCGCGTGCCTCTCATTTGTTATAGGCATATCATTG
[0090] HRSV B-F: CTGGTCCGTACTTCCGAGCGAGGTGTAGGATCTGCAATAGC
[0091] HRSV B-R: TACAGTCGGTCGCGTGCCTCCAATGTTGGAGATGCGACAGC
[0092] InfV A-F: CTGGTCCGTACTTCCGAGCGACAGCATCGGTCTCACAGAC
[0093] InfV A-R: TACAGTCGGTCGCGTGCCTCCTTGAATCGCTGCATCTGCAC
[0094] InfV B-F: CTGGTCCGTACTTCCGAGCGTGTGAGCTTTCATGAAGCATTTG
[0095] InfV B-R: TACAGTCGGTCGCGTGCCTCTTCATAGCTGAGACCATCTGC
[0096]SARS-F: CTGGTCCGTACTTCCGAGCGTACACACCTCACGCGTTG
...
example 2
[0138] It is known that the sample contains human respiratory syncytial virus type B (HRSV-B), and it is detected according to the method of the present invention. The specific steps are the same as in Example 1, and the results of the fluorescence detection value are as follows:
[0139] When the first round of PCR primer F and the first round of PCR primer R in step b are human respiratory syncytial virus type A primers HRSV A-F and HRSV A-R, the probe in step e is human respiratory syncytial virus type A probe HRSV A-probe When the fluorescence detection value is 46, it is confirmed that the sample does not contain human respiratory syncytial virus type A;
[0140]When the first round of PCR primer F and the first round of PCR primer R in step b are human respiratory syncytial virus type B primers HRSV B-F and HRSV B-R, and the probe of step e is human respiratory syncytial virus type B probe HRSV B-probe, The fluorescence detection value was 864, confirming that the sample...
example 3
[0150] It is known that the sample contains influenza virus type A (InfV A), and it is detected according to the method of the present invention. The specific steps are the same as in Example 1, and the results of the fluorescence detection value are as follows:
[0151] When the first round of PCR primer F and the first round of PCR primer R in step b are human respiratory syncytial virus type A primers HRSV A-F and HRSV A-R, the probe in step e is human respiratory syncytial virus type A probe HRSV A-probe When the fluorescence detection value is 12, it is confirmed that the sample does not contain human respiratory syncytial virus type A;
[0152] When the first round of PCR primer F and the first round of PCR primer R in step b are human respiratory syncytial virus type B primers HRSV B-F and HRSV B-R, and the probe of step e is human respiratory syncytial virus type B probe HRSV B-probe, The fluorescence detection value is 34, confirming that the sample does not contain h...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com